Intensity-modulated radiation therapy in head and neck cancers: Dosimetric advantages and update of clinical results

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 4, 2005, Pages 415-423

  Puri, Dev R ^a   Chou, William ^a   Lee, Nancy ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Head and neck cancer; IMRT; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM;

BRAIN STEM; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; DRY EYE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; LYMPHADENOPATHY; MUCOSA INFLAMMATION; NASOPHARYNX CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; PHARYNGITIS; QUALITY OF LIFE; REVIEW; SALIVARY GLAND; SKIN TOXICITY; SPINAL CORD LESION; THYROID CANCER; TUMOR NECROSIS; TUMOR VOLUME; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; OSTEORADIONECROSIS; PACLITAXEL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 23244436980     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000162443.08446.00     Document Type: Review

References (36)

1. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys. 2001;51:880-914.
2. Som PM, Curtin HD, Mancuso AA. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Radiol. 2000; 175:837-844.
3. Gregoire V, Daisne JF, Geets X, et al. Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition. Rays. 2003;28:217-224.
4. Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003;69:227-236.
5. Chao KS, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312-321.
6. Lee N, Xia P, Fischbein NJ, et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57:49-60.
7. Zhen W, Lydiatt W, Lydiatt D, et al. A preliminary analysis of patterns of failure in patients treated with intensity modulated radiotherapy (IMRT) for head and neck cancer: the University of Nebraska Medical Center experience. Int J Radiat Oncol Biol Phys. 2004;60:S318.
8. Marks JE, Bedwinek JM, Lee F. Dose-response analysis for nasopharyngeal carcinoma. Cancer. 1982;50:1042-1050.
9. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59:28-42.
10. Hunt MA, Zelefsky MJ, Wolden S, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys. 2001;49:623-632.
11. Xia P, Lee N, Liu YM, et al. A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system. Int J Radiat Oncol Biol Phys. 2004;59:886-896.
12. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22. [See comment.]
13. Bucci M, Xia P, Lee N, et al. Intensity modulated radiation therapy for carcinoma of the nasopharynx: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2004;60:S317-S318.
14. Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer. 2004;101: 1584-1593.
15. Kam MK, Chau RM, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys. 2003;56:145-157.
16. Xia P, Fu KK, Wong GW, et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:329-337.
17. Lu TX, Mai WY, Teh BS, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:682-687.
18. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16. [See comment.]
19. Hillman JD. Principles of microbial ecology and their application to xerostomia-associated opportunistic infections of the oral cavity. Adv Dent Res. 1996;10:66-68.
20. Ramirez-Amador V, Silverman S Jr, Mayer P, et al. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pathol Oral Raiol Endod. 1997;84:149-153.
21. Lin A, Kim HM, Terrell JE, et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57:61-70.
22. Eisbruch A, Ship JA, Dawson LA, et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg. 2003;27:832-837.
23. Eisbruch A, Ship JA, Martel MK, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Radiat Oncol Biol Phys. 1996;36:469-480.
24. Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577-587. [See comment.]
25. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 2001:907-916.
26. Chao KS, Ozyigit G, Blanco AI, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys. 2004:43-50.
27. 26a. de Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy (IMRT) for advanced oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Presented at: Annual Meeting of the American Society of Clinical Oncology (ASCO); May 14, 2005.
28. Huang K, Lee N, Xia P. Intensity-modulated radiotherapy in the treatment of oropharyngeal carcinoma: a single institutional experience. Int J Radiat Oncol Biol Phys. 2003;57:S302.
29. Garden AS, Morrison W, Rosenthal D, et al. Intensity modulated radiation therapy (IMRT) for metastatic cervical adenopathy from oropharynx carcinoma. Int J Radiat Oncol Biol Phys. 2004;60:S318.
30. Chao KS, Majhail N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol. 2001;61:275-280.
31. Claus F, Boterberg T, Ost P, et al. Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome? Radiother Oncol. 2002;64:205-208.
32. De Neve W, Duthoy W. Intensity-modulated radiation therapy for head and neck cancer. Expert Rev Anticancer Ther. 2004;4:425-434.
33. Nutting CM, Convery DJ, Cosgrove VP, et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol. 2001;60:173-180.
34. Posner MD, Quivey JM, Akazawa PF, et al. Dose optimization for the treatment of anaplastic thyroid carcinoma: a comparison of treatment planning techniques. Int J Radiat Oncol Biol Phys. 2000;48:475-483.
35. 33a. Rosenbluth BD, Serrano V, Hoppersett L, et al. Intensity-modulated radiation therapy (IMRT) for the treatment of non-anaplastic thyroid cancer. Int J Radiat Oncol Biol Phys. In press.
36. Ahamad A, Garden AS, Morrison W. Key lessons from intensity modulated radiation therapy (IMRT) for thyroid cancer. Int J Radiat Oncol Biol Phys. 2004;60:S494.